top of page

LIST OF PUBLICATIONS

OUR WORK: List

1. The Multi-kinase Inhibitor Debio 0617B  educes Maintenance and Self- renewal of Primary Human AML CD34 + Stem/Progenitor Cells
Murone M, Radpour R, Attinger A, Chessex AV, Huguenin AL, Schürch CM, Banz Y, Sengupta S, Aguet M, Rigotti S, Bachhav Y, Massière F, Ramachandra M, McAllister A, Riether C.

-- Mol Cancer Ther. 2017 Aug;16(8):1497-1510

2. Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases
Murone M, Vaslin Chessex A, Attinger A, Ramachandra R, Shetty SJ, Daginakatte G, Sengupta S, Marappan S, Dhodheri S, Rigotti S, Bachhav Y, Brienza S, Traxler P, Lang M, Aguet M, Zoete V, Michielin O, Nicholas C, Johnson FM, Ramachandra M, McAllister A.
-- Mol Cancer Ther. 2016 Oct;15(10):2334-2343

3. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology
Bachhav YG, Heinrich A, Kalia YN
-- Eur J Pharm Biopharm. 2013 Jun;84(2):355-64

4. Using controlled laser-microporation to increase transdermal delivery of prednisone
Yu J, Bachhav YG, Summer S, Heinrich A, Bragagna T, Böhler C, Kalia YN.
-- J Control Release. 2010 Nov 20;148(1):e71-3

5. Using laser microporation to improve transdermal delivery of diclofenac: Increasing bioavailability and the range of therapeutic applications.
Bachhav YG, Heinrich A, Kalia YN
-- Eur J Pharm Biopharm. 2011 Aug;78(3):408-14.

6. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals.
Bachhav YG, Mondon K, Kalia YN, Gurny R, Möller M.
-- J Control Release. 2011 Jul 30;153(2):126-32.

7. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
Bachhav YG, Patravale VB
-- Acta Pharm. 2010 Jun;60(2):153-63.

8. Development and validation of a rapid high-performance liquid chromatography method for the quantification of exenatide.
Bachhav YG, Kalia YN.
-- Biomed Chromatogr. 2011 Jul;25(7):838-42

9. Effect of controlled laser microporation on drug transport kinetics into and across the skin.
Bachhav YG, Summer S, Heinrich A, Bragagna T, Böhler C, Kalia YN.
-- J Control Release. 2010 Aug 17;146(1):31-6.

10. Development and validation of an analytical method for the quantification of cytochrome c in skin transport studies
Bachhav YG, Kalia YN.
-- Biomed Chromatogr. 2010 Jul;24(7):732-6.

11. Stability of triptorelin in the presence of dermis and epidermis.
Bachhav YG, Kalia YN
-- Int J Pharm. 2009 Aug 13;378(1-2):149-51.

12. Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies
Bachhav YG, Patravale VB.
-- AAPS PharmSciTech. 2009;10(2):476-81

13. SMEDDS of glyburide: formulation, in vitro evaluation, and stability studies
Bachhav YG, Patravale VB.
-- AAPS PharmSciTech. 2009;10(2):482-7.

14. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation
Bachhav YG, Patravale VB.
-- Int J Pharm. 2009 Jan 5;365(1-2):175-9.

15. Intraepidermal drug delivery: P.L.E.A.S.E.® - A new laser microporation technology.
Kalia Y.N., Bachhav Y.G., Bragagna T., and Böhler C.
-- Drug Delivery Technology, 2008; 8: 26-31.

16. Exploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systems
Bachhav YG, Date AA, Patravale VB.
-- Int J Pharm. 2006 Dec 1;326(1-2):186-9

Patents

OUR WORK: List

  • Contributed as innovator for generation of valuable intellectual property (8 Patents)

9783527343966.jpg

Book

Innovative Dosage Forms

Design and Development at Early Stage

Bachhav, Yogeshwar (Editor)
Methods and Principles in Medicinal Chemistry

OUR WORK: Welcome

LIST OF CONFERENCE COMMUNICATIONS

1. Effect of laser microporation on Follicle Stimulating Hormone permeation kinetics across porcine skin in vitro Bachhav Y. G., Heinrich A., Bragagna T., Böhler C. and Kalia Y. N. 2009 AAPS Annual Meeting and Exposition, Los Angeles, USA (November 8-12, 2009)

2. Using laser microporation to increase transdermal delivery of Imiquimod Bachhav Y. G., Heinrich A., Bragagna T., Böhler C. and Kalia Y. N. 2009 AAPS Annual Meeting and Exposition, Los Angeles, USA (November 8-12, 2009)

3. Formulation and evaluation of microemulsions for topical delivery of Clotrimazole Lapteva M., Bachhav Y. G. and Kalia Y. N. 2009 AAPS Annual Meeting and Exposition, Los Angeles, USA (November 8-12, 2009)

4. Transdermal delivery kinetics of Haloperidol across laser porated porcine skin in vitro Brühwiler L., Bachhav Y. G. and Kalia Y. N. 2009 AAPS Annual Meeting and Exposition, Los Angeles, USA (November 8-12, 2009)

5. Using laser-assisted microporation to increase delivery of dermatology therapeutics Bachhav Y. G., Heinrich A., Bragagna T., Böhler C., Salomon D., Strohal R. and Kalia Y. N. 18th Congress of the European Academy of Dermatology and Venereology, ICC Berlin (7-11 October 2009)

6. Effect of P.L.E.A.S.E.® Microporation on the transdermal delivery of Cytochrome c Bachhav Y. G., Summer S., Heinrich A., Bragagna T., Böhler C. and Kalia Y. N. 36th Annual Meeting and Exposition of the Controlled Release Society, Copenhagen (Denmark) (July 18-22, 2009)

7. Delivery of intact FITC-labeled Bovine Serum Albumin (70 kDa) across laser porated skin Bachhav Y. G., Summer S., Heinrich A., Bragagna T., Böhler C. and Kalia Y. N. 36th Annual Meeting and Exposition of the Controlled Release Society, Copenhagen (Denmark) (July 18-22, 2009)

8. Microemulsion System for topical delivery of Econazole Nitrate Pastor M., Bachhav Y. G. and Kalia Y.N. 36th Annual Meeting and Exposition of the Controlled Release Society, Copenhagen (Denmark) (July 18-22, 2009)

9. Design and Evaluation of a Topical Delivery System for Clotrimazole Guenat C., Bachhav Y. G. and Kalia Y. N. 36th Annual Meeting and Exposition of the Controlled Release Society, Copenhagen (Denmark) (July 18-22, 2009)

10. Minimally invasive delivery of peptides and proteins across the skin using P.L.E.A.S.E.® technology Bachhav Y. G., Summer S., Heinrich A., Bragagna T., Böhler C. and Kalia Y. N. 2008 AAPS Annual Meeting and Exposition, Atlanta, GA, USA (November 16-20, 2008)

11. Using P.L.E.A.S.E.® technology to increase transdermal delivery of Diclofenac Bachhav Y. G., Summer S., Heinrich A., Bragagna T., Böhler C. and Kalia Y. N. 2008 AAPS Annual Meeting and Exposition, Atlanta, GA, USA (November 16-20, 2008)

12. Optimizing iontophoretic delivery kinetics of diclofenac in vitro Romand A., Cázares-Delgadillo J., Bachhav Y. G. and Kalia Y. N. Swiss Pharma Science Day, Bern, Switzerland (October 9, 2008)

13. P.L.E.A.S.E.® A promising tool for intraepidermal drug delivery Bachhav Y. G., Summer S., Heinrich A., Bragagna T., Böhler C. and Kalia Y. N. 35th Annual Meeting and Exposition of the Controlled Release Society, NY, USA (July 12-16, 2008)

14. Effect of epidermal and dermal tissue on Triptorelin stability in solution and the impact of P.L.E.A.S.E.® treatment on its permeation kinetics across porcine skin in vitro Bachhav Y. G., Summer S., Heinrich A., Bragagna T., Böhler C. and Kalia Y. N. 35th Annual Meeting and Exposition of the Controlled Release Society, NY, USA (July 12-16, 2008)

15. FLUCOCARE: topical nanoemulsion based Fluconazole therapy Bachhav Y. G., Dandekar P. D. and Patravale V.B. 8th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems, Controlled Release society Indian Chapter, Mumbai, India (February 26-27, 2008)

16. Microemulsion based bioadhesive vaginal gel of Fluconazole Bachhav Y. G. and Patravale V. B. Indo-US Symposium on Nanotechnology in Advanced Drug Delivery, NIPER, S. A. S. Nagar, Punjab, India (October 5-6, 2006)

17. Microemulsion based bioadhesive vaginal gel of Clotrimazole Bachhav Y. G. and Patravale V. B. 33rd Annual Meeting and Exposition of the Controlled Release Society, Vienna, Austria (July 22-26, 2006)

18. Comparative evaluation of the effect of pyrrolidones on the phase behavior of ternary systems Bachhav Y. G. and Patravale V. B.33rd Annual Meeting and Exposition of the Controlled Release Society, Vienna, Austria. (July 22 -26, 2006)

19. Effect of 2-pyrrolidone (Soluphor P®) on the phase behavior of ternary systems Bachhav Y. G., Khan I. A. and Patravale V. B. NIPER-NANO-2006, Conference on Nanotechnology in Advanced Drug Delivery, NIPER, SAS Nagar, Punjab, India (February 17-18, 2006)

20. Formulation and evaluation of self-nanoemulsifying drug delivery system of Etoposide Bachhav Y. G., Jain J. M. and Patravale V. B. NIPER-NANO-2006, Conference on Nanotechnology in Advanced Drug Delivery, NIPER, SAS Nagar, Punjab, India (February 17-18, 2006)

21. Formulation and evaluation of self-microemulsifying drug delivery system of Glyburide Bachhav Y. G. and Patravale V. B. 1st Indo-Japanese International Conference on Advances in Pharmaceutical Research and Technology, Hotel Grand Hyaat, Mumbai, India, (November 25-29, 2005)

22. Reverse phase HPLC stability indicating method for analysis of Glyburide as an API and in the formulation
Bachhav Y. G. and Patravale V. B. 1st Indo-Japanese International Conference on Advances in Pharmaceutical Research and Technology, Hotel Grand Hyaat, Mumbai, India.(November 25-29, 2005)

23. Effect of Pharmasolve® on phase behavior of ternary systems Bachhav Y. G., Jain R., Date A. A. and Patravale V. B. 32nd Annual meeting and exposition of the Controlled Release Society, Miami Beach, FL, USA (June 22-25, 2005)

24. A novel carrier for solid dispersion of Tadalafil Bachhav Y. G. and Patravale V. B. 6th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems, Controlled Release society Indian Chapter, Mumbai, India (February 18-19, 2005)

25. Development of Meloxicam topical gel Bachhav Y. G. and Patravale V. B. 2004 AAPS Annual Meeting and Exposition, Baltimore, MD, USA (November 7- 11, 2004)

26. A novel carrier for solid dispersion of Valdecoxib Bachhav Y. G. and Patravale V. B. 2004 AAPS Annual Meeting and Exposition, Baltimore, MD, USA (November 7-11, 2004)

OUR WORK: List
bottom of page